Researchers document third known case of HIV remission involving stem cell transplant
On Feb. 15, 2023, it was reported that a 53-year-old man in Germany had become at least the…
Moderna to provide free COVID-19 vaccines after U.S. public health emergency ends
On Feb. 15, 2023, Moderna announced it will continue to offer its COVID-19 vaccines for free, even after…
Molecular atlas of spider silk published
On Feb. 15, 2023, Researchers from Southwest University in China have constructed the entire chromosomal-scale genome assembly and…
British Columbia Institute of Technology received $14.5 million to support aerospace and life sciences training
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
Equatorial Guinea confirmed first-ever Marburg virus disease outbreak
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
U.S. Government and Novavax extend partnership for 1.5 million additional doses of Novavax’ COVID-19 vaccine
On Feb. 13, 2023, Novavax announced a modification to its existing agreement with the U.S. Department of Health…
FDA authorized first Mpox test
On Feb. 10, 2023, the U.S. Food and Drug Administration issued an emergency use authorization for the first…
Large-scale genetic analysis showed microRNAs in human pancreas associated with diabetes
On Feb. 9, 2023, the National Institutes of Health (NIH) announced that a new large-scale genetic analysis found…
Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | Vaccine | Veterinary
Bird flu has begun to spread in mammals
On Feb. 8, 2023, as bird flu continues to circle the globe, a new report suggested that the…
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Life Science News | Vaccine
BD received FDA EUA for COVID-19, influenza A/B, RSV combination test
On Feb. 8, 2023, BD announced that it had received Emergency Use Authorization from the U.S. Food and…
Bivalent boosters provided better protection against severe COVID-19
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
USDA-ARS scientists announded developing new tests, new ways to track COVID In wild and domestic animals
On Feb. 7, 2023, the U.S. Department of Agricultureﾒs Research Service announced that it was implementing a $300…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | WHO | Women's Health
WHO launched new roadmap on breast cancer
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
Study identified features that may make motor neurons vulnerable to ALS
On Feb. 2, 2023, a team of researchers supported by the National Institutes of Health found evidence linking…
Biotechnology | Disease | Life Science News | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
New MRI method provided detailed view of the placenta during pregnancy
On Feb. 1, 2023, researchers funded by the National Institutes of Health announded they had developed a new…
A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
FDA announced Evusheld is not currently authorized for emergency use in the U.S.
On Jan. 26, 2023, the U.S. Food and Drug Administration revised the Emergency Use Authorization for Evusheld (tixagevimab…
Twist Bioscience began shipping commercial product from synthetic DNA manufacturing factory of the future
On Jan. 26, 2023, Twist Bioscience announced that it had begun offering high-quality synthetic DNA using its silicon…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Vaccine
U.S. household spread of flu more than doubled during the 2021-2022 season compared to pre-COVID-19 pandemic levels
On Jan. 26, 2023, Centers for Disease Control and Prevention (CDC) reported that U.S. household spread of flu…
Roche launched COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant
On Jan. 25, 2023, Roche and its subsidiary TIB Molbiol announced they had developed a COVID-19 PCR test…
Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
OHSU researchers found immune response to COVID-19 strengthens over time
On Jan. 25, 2023, researchers at Oregon Health & Science University (OHSU) reported that Immunity from COVID-19 appears…
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics
Milestones in CRISPR
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
Special drone collects environmental DNA from trees
On Jan. 19, 2023, researchers at ETH Zurich and the Swiss Federal research institute WSL announced they had…
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea as an adult booster
On Jan. 18, 2023, Novavax announced that partner SK bioscience had received expanded manufacturing and marketing approval from…
Biotechnology | HIV | Life Science News | NIH | Vaccine
Experimental HIV vaccine regimen safe but ineffective, study found
On Jan. 18, 2023, the National Institutes of Health (NIH) announced that an investigational HIV vaccine regimen tested…
USDA researchers developed naturally fire-resistant cotton lines
On Jan. 18, 2023, researchers at the U.S. Department of Agriculture’s Agricultural Research Service announced they had bred…
Moderna announced mRNA-1345, an investigational RSV Vaccine, met primary efficacy endpoints in phase 3 trial
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…